Multidrug-Resistant Organisms (MDROs) severely limit treatment options for infected patients, increasing hospital stays, cost of care and mortality.1 Methicillin-resistant Staphylococcus aureus (MRSA), a growing MDRO, has become increasingly prevalent in U.S. hospitals.
1. Centers for Disease Control and Prevention, US Department of Health and Human Services. Multidrug-Resistant Organism & Clostridium difficile-Associated Disease (MDRO/CDAD) Module. Available at: http://cdc.gov/nhsn/PDFs/pscManual/12pscMDRO_CDADcurrent.pdf. Accessed April 1, 2010.
Your visit to this site and use of the information hereon is subject to the terms of our Legal Statement. Please review our Privacy Statement.
